首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1541219

2024-2032 年按產品、應用（低丙種球蛋白血症、慢性發炎性脫髓鞘性多發性神經病變、免疫缺陷症、重症肌無力等）、分娩方式和地區分類的免疫球蛋白市場報告

Immunoglobulin Market Report by Product, Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, and Others), Mode of Delivery, and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球免疫球蛋白市場規模達157億美元。

免疫球蛋白也稱為抗體，是指由血漿或白血球 (WBC) 產生的一類糖蛋白分子。它們通常存在於免疫系統的血清和細胞中，並透過明確識別和結合抗原（例如細菌或病毒）而發揮抗體的作用，並幫助破壞它們。他們的檢驗幫助醫生診斷免疫缺陷、過敏和自體免疫疾病，如幼年特發性關節炎、紅斑性狼瘡和乳糜瀉。目前，世界各地有不同類別的免疫球蛋白，取決於生物學特徵、結構、標靶特異性和分佈。

免疫球蛋白市場趨勢：

由於快速的城市化和繁忙的日程安排，個人速食消費量有所增加。再加上久坐的生活方式以及患有多發性骨髓瘤、華氏巨球蛋白血症和自體免疫疾病等疾病的患者數量不斷增加，是推動市場成長的主要因素之一。此外，人們對早期診斷的認知不斷提高，以及對個人化藥物的偏好不斷增加，也促進了市場的成長。而且，免疫球蛋白透過多種給藥途徑幫助人體對抗各種傳染病。因此，隨著冠狀病毒病（COVID-19）住院患者數量的不斷增加以及迫切需要有效的治療方法來防止大流行的傳播，超免疫球蛋白被用作控制感染的有效藥物。除此之外，一些製藥公司正在推出新型和先進的免疫球蛋白，以提高治療神經系統疾病的效率。其他因素，例如增加研發 (R&D) 專案資金和改善醫療基礎設施等，預計將在未來幾年進一步推動市場成長。

本報告回答的關鍵問題

2023年全球免疫球蛋白市場規模有多大？ 2024-2032年全球免疫球蛋白市場的預期成長率是多少？
推動全球免疫球蛋白市場的關鍵因素是什麼？
COVID-19 對全球免疫球蛋白市場有何影響？
根據應用，全球免疫球蛋白市場的細分如何？
根據交付方式，全球免疫球蛋白市場的詳細情形如何？
全球免疫球蛋白市場的關鍵區域有哪些？
誰是全球免疫球蛋白市場的主要參與者/公司？

Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution.

Immunoglobulin Market Trends:

Due to rapid urbanization and hectic schedules, there is a rise in the consumption of fast food among individuals. This, along with sedentary lifestyles and the increasing number of patients with medical conditions like multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders, represents one of the primary factors impelling the growth of the market. Additionally, rising awareness about early diagnosis and the increasing preferences for personalized medicines are contributing to market growth. Moreover, immunoglobulins through a variety of routes of administration help the body fight various infectious diseases. As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunoglobulin market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and mode of delivery.

Breakup by Product:

IgG

IgA

IgM

IgE

IgD

Breakup by Application:

Hypogammaglobulinemia

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Immunodeficiency Disease

Myasthenia Gravis

Others

Breakup by Mode of Delivery:

Intravenous Mode of Delivery

Subcutaneous Mode of Delivery

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

1. What was the size of the global immunoglobulin market in 2023?
2. What is the expected growth rate of the global immunoglobulin market during 2024-2032?
3. What are the key factors driving the global immunoglobulin market?
4. What has been the impact of COVID-19 on the global immunoglobulin market?
5. What is the breakup of the global immunoglobulin market based on the application?
6. What is the breakup of the global immunoglobulin market based on the mode of delivery?
7. What are the key regions in the global immunoglobulin market?
8. Who are the key players/companies in the global immunoglobulin market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Immunoglobulin Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 IgG
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 IgA
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 IgM
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 IgE
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 IgD
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Hypogammaglobulinemia
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Immunodeficiency Disease
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Myasthenia Gravis
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Mode of Delivery

8.1 Intravenous Mode of Delivery
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Subcutaneous Mode of Delivery
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 ADMA Biologics Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
- 14.3.2 Baxter international Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Biotest AG
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 CSL Limited
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Grifols S.A
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Kedrion S.p.A
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 LFB SA
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Octapharma AG
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 SWOT Analysis
- 14.3.9 Sanquin Plasma Products B.V.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Takeda Pharmaceutical Company Limited
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Immunoglobulin Market: Major Drivers and Challenges
Figure 2: Global: Immunoglobulin Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Immunoglobulin Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Immunoglobulin Market: Breakup by Product (in %), 2023
Figure 5: Global: Immunoglobulin Market: Breakup by Application (in %), 2023
Figure 6: Global: Immunoglobulin Market: Breakup by Mode of Delivery (in %), 2023
Figure 7: Global: Immunoglobulin Market: Breakup by Region (in %), 2023
Figure 8: Global: Immunoglobulin (IgG) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Immunoglobulin (IgG) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Immunoglobulin (IgA) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Immunoglobulin (IgA) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Immunoglobulin (IgM) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Immunoglobulin (IgM) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Immunoglobulin (IgE) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Immunoglobulin (IgE) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Immunoglobulin (IgD) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Immunoglobulin (IgD) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Immunoglobulin (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Immunoglobulin (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Immunoglobulin (Immunodeficiency Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Immunoglobulin (Immunodeficiency Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Immunoglobulin (Myasthenia Gravis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Immunoglobulin (Myasthenia Gravis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Immunoglobulin (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Immunoglobulin (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Immunoglobulin (Intravenous Mode of Delivery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Immunoglobulin (Intravenous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Immunoglobulin Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Immunoglobulin Industry: SWOT Analysis
Figure 82: Global: Immunoglobulin Industry: Value Chain Analysis
Figure 83: Global: Immunoglobulin Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Immunoglobulin Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Immunoglobulin Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Immunoglobulin Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Immunoglobulin Market Forecast: Breakup by Mode of Delivery (in Million US$), 2024-2032
Table 5: Global: Immunoglobulin Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Immunoglobulin Market: Competitive Structure
Table 7: Global: Immunoglobulin Market: Key Players

02-2729-4219

+886-2-2729-4219